�鶹��ýӰ��

Geriatrics >

Parkinson's Disease

News, opinions and meeting coverage in geriatrics.

FDA Eyeing Patient-Reported Outcomes in Huntington's, Parkinson's

Some non-motor symptoms may be ideal 'PRO' candidates

Wise Buy? Focused Ultrasound Therapies

Exciting technology, but now sold to patients on slim supporting evidence

Novel Parkinson Therapies Highlighted at AAN Meeting

Early results with gene therapy, new carbidopa-levodopa formulation featured

Fraud Rounds: Four Retractions Tallied for PD Researcher Spared Jail

Faking co-author signatures, consent forms, and duplication adds up

ADHD Drug Fails to Boost Cognition in Parkinson's

But patients reported improvements in impulsivity, inattention

Quick Enrollment for STEADY-PD III Trial

Researchers enrolled 336 early Parkinson's patients within a year

Parkinson's GI Issues More Complex than Constipation

Study reveals IBS risk

Anxiety Overlooked in Parkinson's?

Longitudinal study finds 16% have baseline anxiety, 37% develop it over time

Physical Therapy Underused in Parkinson's

Only 11% of patients had used it in Medicare study

PD Patients Report Better Sleep With Rotigotine Tx

Patch form of dopamine agonist also lowered nighttime activity

Inhaled Levodopa May Bridge Parkinson's 'Off' Periods

Inhaler eased breakthrough motor symptoms between standard levodopa doses in an early study

Subcutaneous Apomorphine Gets Parkinson's Patient Moving Quickly

Most patients respond to injected drug within 20 minutes

Stroke Survivors May Face Greater Cancer Risk

Ischemic stroke increased likelihood of cancer within 2 years of the event.

FDA OKs Northera for Hypotension

The FDA has approved droxidopa (Northera) for the treatment of neurogenic orthostatic hypotension, a rare disease that results in a drop in blood pressure when patients try to stand up.

Droxidopa for OH Slammed by FDA Reviewers

SILVER SPRING, Md. -- Droxidopa (Northera) is getting a second look by an FDA advisory committee for the treatment of orthostatic hypotension stemming from neurological disorders like Parkinson's disease, but an agency review doesn't look promising for approval.

Aricept Helps Cognition in Parkinson's

SYDNEY -- Parkinson's disease patients who have impaired cognition appeared to benefit from the Alzheimer's disease medicine donepezil (Aricept) with no detriment to their motor skills, researchers reported here.

Eye Tremors May Be Early Sign of Parkinson's

Eye tremors are pervasive in Parkinson's disease and could be an early warning sign of the neurodegenerative movement disorder, according to a case-control study.

Parkinson's Called Hidden Killer

Life expectancy for patients with Parkinson's disease is poorer than some previous studies have suggested, with barely one-third of patients surviving six years with the condition, researchers said.

Jumpy Legs in Parkinson's Likely Not RLS

Patients with early Parkinson's disease were more likely to have a movement disorder called leg motor restlessness than true restless legs syndrome, a study found.

Parkinson's Drug Doesn't Slow Disease Progress, FDA Staff Says

WASHINGTON -- Azilect (rasagiline), which is already approved to treat symptoms of Parkinson's disease, does not appear effective at slowing progression of the neurodegenerative disease, according to an FDA review.

FDA Blocks Sale of Supplements for Parkinson's and Alzheimer's

WASHINGTON -- The FDA filed a permanent injunction against two Minnesota companies that distributed amino acid products marketed as treatments for Parkinson's disease, Alzheimer's disease, and a number of other neurological disorders.